Gilead Nears Deal To Buy Immunomedics For More Than $20 Billion - WSJ

Gilead Sciences Inc is nearing a deal to buy biopharmaceutical company Immunomedics Inc for more than $20 billion in a deal that would further expand Gilead's portfolio of cancer treatments, the Wall Street Journal reported on Saturday.

from Top Business News- News18.com https://ift.tt/35xlL3y